• 90 Citations
  • 5 h-Index
20182020
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Elisa Gremese is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Rheumatoid Arthritis Medicine & Life Sciences
Psoriatic Arthritis Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Inflammatory Bowel Diseases Medicine & Life Sciences
Arthritis Medicine & Life Sciences
Systemic Scleroderma Medicine & Life Sciences
Tumor Necrosis Factor-alpha Medicine & Life Sciences
LY2439821 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2018 2020

  • 90 Citations
  • 5 h-Index
  • 24 Article
  • 5 Review article
  • 1 Editorial

Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors

The Italian Study Group on Lung Involvement in Rheumatic Diseases and the Italian Vasculitis Study Group, Jan 1 2020, (Accepted/In press) In : Journal of Autoimmunity. 102397.

Research output: Contribution to journalArticle

Validation Studies
Interstitial Lung Diseases
Rheumatoid Arthritis
Tomography
Equipment and Supplies

Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device)

Manfredi, A., Cassone, G., Cerri, S., Venerito, V., Fedele, A. L., Trevisani, M., Furini, F., Addimanda, O., Pancaldi, F., Della Casa, G., D'Amico, R., Vicini, R., Sandri, G., Torricelli, P., Celentano, I., Bortoluzzi, A., Malavolta, N., Meliconi, R., Iannone, F., Gremese, E. & 3 others, Luppi, F., Salvarani, C. & Sebastiani, M., Jun 20 2019, In : BMC Pulmonary Medicine. 19, 1

Research output: Contribution to journalArticle

17 Citations (Scopus)
Open Access
LY2439821
Tumor Necrosis Factor-alpha
Placebos
Safety
Therapeutics
5 Citations (Scopus)

Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response

Vitale, A., Cavalli, G., Colafrancesco, S., Priori, R., Valesini, G., Argolini, L. M., Baldissera, E., Bartoloni, E., Cammelli, D., Canestrari, G., Sota, J., Cavallaro, E., Massaro, M. G., Ruscitti, P., Cipriani, P., De Marchi, G., De Vita, S., Emmi, G., Ferraccioli, G., Frassi, M. & 28 others, Gerli, R., Gremese, E., Iannone, F., Lapadula, G., Lopalco, G., Manna, R., Mathieu, A., Montecucco, C., Mosca, M., Piazza, I., Piga, M., Pontikaki, I., Romano, M., Rossi, S., Rossini, M., Silvestri, E., Stagnaro, C., Talarico, R., Tincani, A., Viapiana, O., Vitiello, G., Galozzi, P., Sfriso, P., Gaggiano, C., Rigante, D., Dagna, L., Giacomelli, R. & Cantarini, L., Jan 1 2019, In : Frontiers in Pharmacology. 10, APR, 296.

Research output: Contribution to journalArticle

Open Access
Adult-Onset Still's Disease
Interleukin 1 Receptor Antagonist Protein
Antirheumatic Agents
Therapeutics
Joints